MiR-140-5p was reported to suppress VEGF-A and inhibit angiogenesis, as well as to downregulate MMP9 expression and reduce BCCs invasion; moreover, it is decreased in human BC samples and BC metastasis comparing with the corresponding adjacent normal tissues and cancer without metastasis. The gene discussed is MMP9; the disease is breast cancer.